FDA NDC Directory · JSON-LD · Markdown

OMLYCLO

NDC 72606-054 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameomalizumab-igec
Labeler / ManufacturerCELLTRION USA, Inc.
Marketing categoryBiologic License Application · App BLA761399
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsOMALIZUMAB (300 mg/2mL)
Marketing started20261005
Package count2

External sources

Source: openFDA. Public-domain (CC0).